Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Aug;63(8):2859–2866. doi: 10.1128/iai.63.8.2859-2866.1995

A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.

K Sato 1, Y C Yoo 1, A Fukushima 1, I Saiki 1, T A Takahashi 1, M Fujihara 1, S Tono-Oka 1, I Azuma 1
PMCID: PMC173388  PMID: 7622206

Abstract

Bacterial endotoxin (lipopolysaccharide [LPS]) causes severe damage to the host organism as a result of excessive release of inflammatory cytokines, including interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-alpha), from mononuclear phagocytes during gram-negative bacterial infection. We evaluated the ability of a novel synthetic lipid A analog with low endotoxicity, DT-5461, to antagonize LPS-induced IL-1 and TNF-alpha production in cells of monocyte/macrophage lineage and examined the protective effect of DT-5461 against lethal endotoxic shock in mice. The IL-1- or TNF-alpha-inducing activity of DT-5461 is 100,000 to 10,000 times less active than that of Escherichia coli LPS (EcLPS) or synthetic lipid A. DT-5461 significantly inhibited EcLPS-induced IL-1 and TNF-alpha release when murine peritoneal macrophages were incubated with DT-5461 2 h prior to EcLPS stimulation at the same concentration (1 microgram/ml). The antagonistic effect of DT-5461 on the production of IL-1 and TNF-alpha induced by EcLPS occurred in a concentration-dependent manner. DT-5461 also inhibited IL-1 and TNF-alpha induction when murine peritoneal macrophages were stimulated by LPS from Salmonella typhimurium or synthetic lipid A, as well as by EcLPS, but not by muramyl dipeptides. This indicated that DT-5461 specifically antagonized the action of LPS. DT-5461 also antagonized EcLPS-mediated activation of human peripheral blood monocytes. DT-5461 blocked the binding of fluorescein isothiocyanate-labelled LPS to murine peritoneal macrophages as well as it did the binding of EcLPS and synthetic lipid A, i.e., in a concentration-dependent fashion. Injection of DT-5461 2 h before EcLPS challenge prevented the production of serum IL-1 and TNF-alpha in D-galactosamine-treated mice. Furthermore, this treatment modality protected mice against LPS-induced lethal toxicity. This study suggests that DT-5461 possesses a potent LPS antagonistic effect and may be useful in a protective strategy against lethal endotoxemia caused by gram-negative bacterial infection.

Full Text

The Full Text of this article is available as a PDF (355.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner J. D., Glauser M. P. Immunotherapy of endotoxemia and septicemia. Immunobiology. 1993 Apr;187(3-5):464–477. doi: 10.1016/S0171-2985(11)80357-8. [DOI] [PubMed] [Google Scholar]
  2. Billiau A., Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest. 1991 Dec;21(6):559–573. doi: 10.1111/j.1365-2362.1991.tb01410.x. [DOI] [PubMed] [Google Scholar]
  3. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corradin S. B., Mauël J., Gallay P., Heumann D., Ulevitch R. J., Tobias P. S. Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein. J Leukoc Biol. 1992 Oct;52(4):363–368. doi: 10.1002/jlb.52.4.363. [DOI] [PubMed] [Google Scholar]
  5. Dentener M. A., Bazil V., Von Asmuth E. J., Ceska M., Buurman W. A. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol. 1993 Apr 1;150(7):2885–2891. [PubMed] [Google Scholar]
  6. Freudenberg M. A., Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun. 1988 May;56(5):1352–1357. doi: 10.1128/iai.56.5.1352-1357.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Galanos C., Freudenberg M. A. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology. 1993 Apr;187(3-5):346–356. doi: 10.1016/S0171-2985(11)80349-9. [DOI] [PubMed] [Google Scholar]
  8. Golenbock D. T., Hampton R. Y., Qureshi N., Takayama K., Raetz C. R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem. 1991 Oct 15;266(29):19490–19498. [PubMed] [Google Scholar]
  9. Golenbock D. T., Will J. A., Raetz C. R., Proctor R. A. Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin. Infect Immun. 1987 Oct;55(10):2471–2476. doi: 10.1128/iai.55.10.2471-2476.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hailman E., Lichenstein H. S., Wurfel M. M., Miller D. S., Johnson D. A., Kelley M., Busse L. A., Zukowski M. M., Wright S. D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med. 1994 Jan 1;179(1):269–277. doi: 10.1084/jem.179.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Henricson B. E., Perera P. Y., Qureshi N., Takayama K., Vogel S. N. Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A. Infect Immun. 1992 Oct;60(10):4285–4290. doi: 10.1128/iai.60.10.4285-4290.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heumann D., Gallay P., Barras C., Zaech P., Ulevitch R. J., Tobias P. S., Glauser M. P., Baumgartner J. D. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol. 1992 Jun 1;148(11):3505–3512. [PubMed] [Google Scholar]
  13. Kirkland T. N., Qureshi N., Takayama K. Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS. Infect Immun. 1991 Jan;59(1):131–136. doi: 10.1128/iai.59.1.131-136.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kumazawa E., Tohgo A., Soga T., Kusama T., Osada Y. Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models. Cancer Immunol Immunother. 1992;35(5):307–314. doi: 10.1007/BF01741143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kusama T., Soga T., Ono Y., Kumazawa E., Shioya E., Nakayama K., Uoto K., Osada Y. Synthesis and biological activities of lipid A analogs: modification of a glycosidically bound group with chemically stable polar acidic groups and lipophilic groups on the disaccharide backbone with tetradecanoyl or N-dodecanoylglycyl groups. Chem Pharm Bull (Tokyo) 1991 Dec;39(12):3244–3253. doi: 10.1248/cpb.39.3244. [DOI] [PubMed] [Google Scholar]
  16. Lesslauer W., Tabuchi H., Gentz R., Brockhaus M., Schlaeger E. J., Grau G., Piguet P. F., Pointaire P., Vassalli P., Loetscher H. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol. 1991 Nov;21(11):2883–2886. doi: 10.1002/eji.1830211134. [DOI] [PubMed] [Google Scholar]
  17. Morrison D. C., Lei M. G., Kirikae T., Chen T. Y. Endotoxin receptors on mammalian cells. Immunobiology. 1993 Apr;187(3-5):212–226. doi: 10.1016/S0171-2985(11)80340-2. [DOI] [PubMed] [Google Scholar]
  18. Morrison D. C., Ryan J. L. Endotoxins and disease mechanisms. Annu Rev Med. 1987;38:417–432. doi: 10.1146/annurev.me.38.020187.002221. [DOI] [PubMed] [Google Scholar]
  19. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  20. Pedron T., Girard R., Eustache J., Bulusu A. R., Macher I., Radzyner-Vyplel H., Stütz P. L., Chaby R. New synthetic analogs of lipid A as lipopolysaccharide agonists or antagonists of B lymphocyte activation. Int Immunol. 1992 Apr;4(4):533–540. doi: 10.1093/intimm/4.4.533. [DOI] [PubMed] [Google Scholar]
  21. Proctor R. A., Will J. A., Burhop K. E., Raetz C. R. Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun. 1986 Jun;52(3):905–907. doi: 10.1128/iai.52.3.905-907.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Qureshi N., Takayama K., Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun. 1991 Jan;59(1):441–444. doi: 10.1128/iai.59.1.441-444.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Saiki I., Maeda H., Murata J., Takahashi T., Sekiguchi S., Kiso M., Hasegawa A., Azuma I. Production of interleukin 1 from human monocytes stimulated by synthetic lipid A subunit analogues. Int J Immunopharmacol. 1990;12(3):297–305. doi: 10.1016/0192-0561(90)90085-2. [DOI] [PubMed] [Google Scholar]
  24. Sato K., Saiki I., Yoo Y. C., Igarashi Y., Kiso M., Hasegawa A., Azuma I. DT-5461, a new synthetic lipid A analogue, inhibits lung and liver metastasis of tumor in mice. Jpn J Cancer Res. 1992 Oct;83(10):1081–1087. doi: 10.1111/j.1349-7006.1992.tb02725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Takahashi T., Hirsh A., Erbe E. F., Bross J. B., Steere R. L., Williams R. J. Vitrification of human monocytes. Cryobiology. 1986 Apr;23(2):103–115. doi: 10.1016/0011-2240(86)90001-5. [DOI] [PubMed] [Google Scholar]
  26. Ulmer A. J., Feist W., Heine H., Kirikae T., Kirikae F., Kusumoto S., Kusama T., Brade H., Schade U., Rietschel E. T. Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Infect Immun. 1992 Dec;60(12):5145–5152. doi: 10.1128/iai.60.12.5145-5152.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Van Dervort A. L., Doerfler M. E., Stuetz P., Danner R. L. Antagonism of lipopolysaccharide-induced priming of human neutrophils by lipid A analogs. J Immunol. 1992 Jul 1;149(1):359–366. [PubMed] [Google Scholar]
  28. Zuckerman S. H., Bendele A. M. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models. Infect Immun. 1989 Oct;57(10):3009–3013. doi: 10.1128/iai.57.10.3009-3013.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zuckerman S. H., Qureshi N. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun. 1992 Jul;60(7):2581–2587. doi: 10.1128/iai.60.7.2581-2587.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zuckerman S. H., Shellhaas J., Butler L. D. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol. 1989 Feb;19(2):301–305. doi: 10.1002/eji.1830190213. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES